Herpes Zoster (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Herpes Zoster" in German language version.

refsWebsite
Global rank German rank
2nd place
3rd place
4th place
7th place
4,845th place
310th place
low place
low place
low place
3,159th place
low place
low place
low place
1,296th place
3,043rd place
200th place
3,329th place
378th place
218th place
968th place
5,401st place
312th place
low place
low place
2,374th place
1,391st place
low place
2,661st place
8,614th place
583rd place
2,508th place
228th place

aerzteblatt.de

awmf.org

beipackzetteln.de

  • Zostex. Beipackzettel, abgerufen am 16. Juli 2017.

cdc.gov

doi.org

  • B. Ultsch et al.: Herpes zoster in Germany: Quantifying the burden of disease. In: BioMed Central (BMC): Infectious Diseases. 2011, Nr. 11, S. 173, doi:10.1186/1471-2334-11-173.
  • James J. Rusthoven et al.: Varicella-zoster infection in adult cancer patients. A population study. In: Archives of Internal Medicine. Band 148, Nr. 7, Juli 1988, S. 1561–1566, doi:10.1001/archinte.1988.00380070065016, PMID 3382302.
  • William B. Hoppenjans et al.: Prolonged cutaneous herpes zoster in acquired immunodeficiency syndrome. In: Archives of Dermatology. Band 126, Nr. 8, August 1990, S. 1048–1050, doi:10.1001/archderm.1990.01670320072012, PMID 2166483.
  • Rhonda G. Kost, Stephen E. Straus: Postherpetic neuralgia--pathogenesis, treatment, and prevention. In: The New England Journal of Medicine. Band 335, Nr. 1, 4. Juli 1996, S. 32–42, doi:10.1056/NEJM199607043350107, PMID 8637540.
  • Mark W. Ragozzino et al.: Risk of cancer after herpes zoster: a population-based study. In: The New England Journal of Medicine. 12. August 1982, Band 307, Nr. 7, S. 393–397, PMID 6979711, doi:10.1056/NEJM198208123070701.
  • W. Meister et al.: Demography, symptomatology, and course of disease in ambulatory zoster patients. A physician-based survey in Germany. In: Intervirology. Band 41, Nr. 6, 1998, S. 272–277, doi:10.1159/000024949, PMID 10325537.
  • C. Sweeney, D. Gilden: Ramsay Hunt syndrome. In: Journal of Neurology, Neurosurgery, and Psychiatry. August 2001, Band 71, Nummer 2, S. 149–154, doi:10.1136/jnnp.71.2.149.
  • G. Bloss et al.: Bilateraler asymmetrischer Zoster im Jugendalter. In: Der Hautarzt. Band 52, Nr. 4, 1. März 2001, S. 335–338, doi:10.1007/s001050051318.
  • Judith Breuer, Maud Pacou, Aline Gauthier, Martin M. Brown: Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK. In: Neurology. Online-Veröffentlichung vor Druck am 2. Januar 2014, doi:10.1212/WNL.0000000000000038.
  • Alison Ruprecht et al.: Notes from the Field: Expanded Laboratory Testing for Varicella - Minnesota, 2016-2023. In: MMWR. Morbidity and mortality weekly report. Band 73, Nr. 11, 21. März 2024, S. 245–246, doi:10.15585/mmwr.mm7311a3, PMID 38512771 (englisch).
  • Sawko W. Wassilew et al.: Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study. In: Antiviral Research. Band 59, Nr. 1, Juni 2003, S. 49–56, doi:10.1016/s0166-3542(03)00065-2, PMID 12834860.
  • Sawko W. Wassilew et al.: Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia. In: Antiviral Research. Band 59, Nr. 1, Juni 2003, S. 57–60, doi:10.1016/s0166-3542(03)00064-0, PMID 12834861.
  • Sawko W. Wassilew, Collaborative Brivudin PHN Study Group: Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study. In: Journal of the European Academy of Dermatology and Venereology: JEADV. Band 19, Nr. 1, Januar 2005, S. 47–55, doi:10.1111/j.1468-3083.2004.01119.x, PMID 15649191.
  • R. W. Johnson, A. S. Rice: Clinical practice. Postherpetic neuralgia. In: The New England Journal of Medicine. 16. Oktober 2014, Band 371, Nr. 16, S. 1526–1533, doi:10.1056/NEJMcp1403062.
  • M. N. Oxman, M. J. Levin, G. R. Johnson et al.: A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults. In: New England Journal of Medicine. 2. Juni 2005, Nr. 352, S. 2271–2284; doi:10.1056/NEJMoa051016 („Shingles prevention study“).
  • Juliana de Oliveira Gomes et al.: Vaccines for preventing herpes zoster in older adults. In: The Cochrane Database of Systematic Reviews. Band 10, Nr. 10, 2. Oktober 2023, S. CD008858, doi:10.1002/14651858.CD008858.pub5, PMID 37781954 (englisch).
  • A. C. Tricco, W. Zarin, R. Cardoso, A. A. Veroniki et al.: Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis. In: BMJ, Band 363, Oktober 2018, S. k4029; doi:10.1136/bmj.k4029, PMID 30361202, PMC 6201212 (freier Volltext).
  • P. O. Lang, R. Aspinall: Vaccination for quality of life: herpes-zoster vaccines. In: Aging clinical and experimental research. Band 33, Nummer 4, April 2021, S. 1113–1122, doi:10.1007/s40520-019-01374-5, PMID 31643072 (Review).

fu-berlin.de

refubium.fu-berlin.de

  • Dietmar Busch: Varizella-Zoster-Virus: Windpocken und Herpes Zoster – Eine szientometrische Analyse. Dissertation, Institut für Arbeitsmedizin der Medizinischen Fakultät Charité – Universitätsmedizin Berlin, Berlin 2011, S. 3: 1.3.1 Primärinfektion. (Volltext als PDF).

gesundheit.de

  • Gürtelrose. Auf: gesundheit.de; abgerufen am 15. September 2013.

guertelrose-infektion.de

  • Anna Nilsson: Gürtelrose am Kopf. guertelrose-infektion.de, 9. September 2013; abgerufen am 24. März 2016.
  • Lea Schnurbus, M. Foerster: Herpes Zoster. Auf: www.guertelrose-infektion.de, aktualisiert am 26. Mai 2013, abgerufen am 15. September 2013.

impfen.de

medizin-transparent.at

nejm.org

nih.gov

ncbi.nlm.nih.gov

  • James J. Rusthoven et al.: Varicella-zoster infection in adult cancer patients. A population study. In: Archives of Internal Medicine. Band 148, Nr. 7, Juli 1988, S. 1561–1566, doi:10.1001/archinte.1988.00380070065016, PMID 3382302.
  • William B. Hoppenjans et al.: Prolonged cutaneous herpes zoster in acquired immunodeficiency syndrome. In: Archives of Dermatology. Band 126, Nr. 8, August 1990, S. 1048–1050, doi:10.1001/archderm.1990.01670320072012, PMID 2166483.
  • Rhonda G. Kost, Stephen E. Straus: Postherpetic neuralgia--pathogenesis, treatment, and prevention. In: The New England Journal of Medicine. Band 335, Nr. 1, 4. Juli 1996, S. 32–42, doi:10.1056/NEJM199607043350107, PMID 8637540.
  • R. Edgar Hope-Simpson: The Nature of Herpes Zoster: A Long-term Study and a New Hypothesis. In: Proceedings of the Royal Society of Medicine. Januar 1965, Band 58, Nr. 1, S. 9–20, PMC 1898279 (freier Volltext), PMID 14267505.
  • Mark W. Ragozzino et al.: Risk of cancer after herpes zoster: a population-based study. In: The New England Journal of Medicine. 12. August 1982, Band 307, Nr. 7, S. 393–397, PMID 6979711, doi:10.1056/NEJM198208123070701.
  • W. Meister et al.: Demography, symptomatology, and course of disease in ambulatory zoster patients. A physician-based survey in Germany. In: Intervirology. Band 41, Nr. 6, 1998, S. 272–277, doi:10.1159/000024949, PMID 10325537.
  • J. L. Meier, S. E. Straus: Comparative biology of latent varicella-zoster virus and herpes simplex virus infections. In: The Journal of infectious diseases. Nr. 166, Supplement 1, August 1992, S. 13–23, PMID 1320646.
  • P. R. Cohen, V. P. Beltrani, M. E. Grossman: Disseminated herpes zoster in patients with human immunodeficiency virus infection. In: The American Journal of Medicine. Band 84, Nr. 6, Juni 1988, S. 1076–1080, PMID 3376978.
  • Alison Ruprecht et al.: Notes from the Field: Expanded Laboratory Testing for Varicella - Minnesota, 2016-2023. In: MMWR. Morbidity and mortality weekly report. Band 73, Nr. 11, 21. März 2024, S. 245–246, doi:10.15585/mmwr.mm7311a3, PMID 38512771 (englisch).
  • Sawko W. Wassilew et al.: Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study. In: Antiviral Research. Band 59, Nr. 1, Juni 2003, S. 49–56, doi:10.1016/s0166-3542(03)00065-2, PMID 12834860.
  • Sawko W. Wassilew et al.: Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia. In: Antiviral Research. Band 59, Nr. 1, Juni 2003, S. 57–60, doi:10.1016/s0166-3542(03)00064-0, PMID 12834861.
  • Sawko W. Wassilew, Collaborative Brivudin PHN Study Group: Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study. In: Journal of the European Academy of Dermatology and Venereology: JEADV. Band 19, Nr. 1, Januar 2005, S. 47–55, doi:10.1111/j.1468-3083.2004.01119.x, PMID 15649191.
  • X. Rabasseda: Brivudine: a herpes virostatic with rapid antiviral activity and once-daily dosing. In: Drugs of today (Barcelona, Spain: 1998.). Mai 2003, Band 39, Nr. 5, S. 359–371; PMID 12861349.
  • Juliana de Oliveira Gomes et al.: Vaccines for preventing herpes zoster in older adults. In: The Cochrane Database of Systematic Reviews. Band 10, Nr. 10, 2. Oktober 2023, S. CD008858, doi:10.1002/14651858.CD008858.pub5, PMID 37781954 (englisch).
  • A. C. Tricco, W. Zarin, R. Cardoso, A. A. Veroniki et al.: Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis. In: BMJ, Band 363, Oktober 2018, S. k4029; doi:10.1136/bmj.k4029, PMID 30361202, PMC 6201212 (freier Volltext).
  • P. O. Lang, R. Aspinall: Vaccination for quality of life: herpes-zoster vaccines. In: Aging clinical and experimental research. Band 33, Nummer 4, April 2021, S. 1113–1122, doi:10.1007/s40520-019-01374-5, PMID 31643072 (Review).

pei.de

pharmazeutische-zeitung.de

rki.de

sachsen.de

revosax.sachsen.de